A critical discovery in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in several types of malignancies, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research